The patent expiry of a popular weight loss drug is expected to lead to a significant price reduction, with generic versions potentially costing up to 60% less. This development could make the drug, currently expensive, more accessible to a wider population struggling with obesity and related health issues. The entry of generic manufacturers will increase competition, driving down prices and expanding market access. While this offers a ray of hope for many, ensuring the quality and efficacy of generic versions will be crucial. This shift could have a substantial impact on public health, making effective weight management more affordable and widespread.
- The patent expiry of a popular weight loss drug is expected to reduce its cost by up to 60% through generic versions.
- This price reduction will significantly increase the accessibility of the drug for a wider population struggling with obesity.
- Increased competition from generic manufacturers is the primary driver for the anticipated price drop.
A study indicates a significant correlation between parental stress and an increased risk of childhood obesity. The research suggests that high levels of stress experienced by parents can lead to lifestyle choices and parenting practices that contribute to children gaining excess weight. This includes factors like reliance on unhealthy convenience foods, reduced physical activity, and emotional eating within the family. The findings highlight the importance of addressing parental mental health as a component of childhood obesity prevention strategies. Interventions aimed at reducing parental stress and promoting healthy family environments could play a crucial role in combating the rising rates of childhood obesity.
- Parental stress is significantly linked to an increased risk of childhood obesity.
- High parental stress can lead to lifestyle choices and parenting practices that contribute to children's weight gain.
- Factors include reliance on unhealthy convenience foods, reduced physical activity, and emotional eating patterns.
A new oral drug is showing promise as a treatment for obstructive sleep apnea (OSA), a condition characterized by repeated breathing interruptions during sleep. Unlike current treatments like CPAP machines, this pill aims to address the underlying physiological mechanisms of OSA. Early clinical trials indicate that the drug can improve airway muscle tone and reduce the frequency of breathing pauses, leading to better sleep quality and reduced daytime sleepiness. While more extensive research is needed to confirm its long-term efficacy and safety, this development offers a potentially convenient and less invasive alternative for millions suffering from sleep apnea, significantly improving their quality of life.
- A new oral drug is being developed as a potential treatment for obstructive sleep apnea (OSA).
- The pill aims to address the physiological causes of OSA, offering an alternative to CPAP machines.
- Early trials suggest the drug can improve airway muscle tone and reduce breathing interruptions during sleep.
Researchers are exploring the therapeutic potential of a psilocybin-derived drug for treating depression and anxiety. Unlike traditional antidepressants, this compound, a synthetic derivative of psilocybin found in magic mushrooms, targets specific serotonin receptors in the brain, potentially offering rapid and sustained relief. Early studies indicate that it can promote neuroplasticity and alter brain connectivity, which may help reset neural pathways associated with mood disorders. The research is in its early stages, but the findings suggest a promising new avenue for mental health treatment, especially for patients who do not respond to conventional therapies, with potential for fewer side effects and a different mechanism of action.
- A synthetic derivative of psilocybin, found in magic mushrooms, is being investigated for treating depression and anxiety.
- The drug targets specific serotonin receptors, potentially offering rapid and sustained relief for mood disorders.
- It promotes neuroplasticity and alters brain connectivity, which may help reset neural pathways associated with depression.
A study suggests that colour blindness might mask early signs of cancer, particularly in bladder cancer, making detection more challenging. The research indicates that individuals with certain types of colour vision deficiency might struggle to identify subtle colour changes in urine or other bodily fluids that could signal early-stage cancer. This delay in detection can lead to more advanced disease at diagnosis, impacting treatment outcomes. The findings highlight the need for increased awareness among colour-blind individuals and healthcare providers, potentially leading to specialized screening methods or diagnostic tools tailored to those with colour vision deficiencies to ensure timely cancer detection.
- Colour blindness may hinder the early detection of certain cancers, particularly bladder cancer.
- Individuals with colour vision deficiency might miss subtle colour changes in bodily fluids that indicate early-stage cancer.
- Delayed cancer detection can lead to more advanced disease at diagnosis and poorer treatment outcomes.
Researchers have developed a new antibiotic that effectively targets harmful bacteria while preserving beneficial gut microbes. This breakthrough addresses a major challenge with conventional antibiotics, which often indiscriminately kill both good and bad bacteria, leading to side effects and antibiotic resistance. The new compound, derived from a natural product, shows potent activity against pathogens like MRSA without disrupting the gut microbiome. This selective action could revolutionize antibiotic therapy, reducing collateral damage to the gut ecosystem and potentially mitigating the rise of antibiotic-resistant strains, offering a more targeted and sustainable approach to treating bacterial infections.
- A new antibiotic has been developed that selectively targets harmful bacteria while preserving beneficial gut microbes.
- Conventional antibiotics often cause collateral damage by killing both good and bad bacteria, leading to side effects and resistance.
- The new compound, derived from a natural product, demonstrates potent activity against pathogens like MRSA.
Artificial Intelligence (AI) is increasingly being integrated into healthcare, primarily functioning as a triage tool to assist doctors, not replace them in making final decisions. AI systems can analyze vast amounts of data, identify patterns, and provide diagnostic support, thereby improving efficiency and accuracy in areas like radiology, pathology, and dermatology. This allows doctors to focus on complex cases and patient interaction. While AI enhances diagnostic capabilities and streamlines processes, human oversight remains crucial for ethical considerations, personalized care, and addressing nuanced patient needs. The future of AI in healthcare lies in augmenting human intelligence, leading to better patient outcomes and more efficient healthcare delivery.
- AI is primarily functioning as a triage and diagnostic support tool in healthcare, not replacing doctors' final decision-making.
- AI enhances efficiency and accuracy in areas like radiology, pathology, and dermatology by analyzing large datasets.
- The integration of AI allows doctors to focus on complex cases, patient interaction, and personalized care.
The Supreme Court of India is set to review its 2018 guidelines on passive euthanasia and living wills, prompted by concerns over their practical implementation. The existing framework, which allows individuals to refuse medical treatment in advance, has faced challenges due to complex procedural requirements, including multiple layers of medical board approvals. The review aims to simplify these procedures to make the "right to die with dignity" more accessible and effective for terminally ill patients. This involves balancing individual autonomy with safeguards against misuse, ensuring that the process is less cumbersome while upholding ethical and legal considerations.
- The Supreme Court is reviewing its 2018 guidelines on passive euthanasia and living wills due to implementation difficulties.
- The current guidelines, while upholding the "right to die with dignity," involve complex procedural requirements and multiple medical board approvals.
- The review aims to simplify the process to make passive euthanasia more accessible for terminally ill patients.
In a landmark ruling, the Supreme Court approved passive euthanasia for Harish Rana, who was in a persistent vegetative state for 13 years, marking India's first judicial approval. The Court clarified that the 'right to live with dignity' under Article 21 includes the 'right to die with dignity' for patients with irreversible medical conditions. It distinguished passive euthanasia as the removal of an artificial barrier, allowing natural trajectory, from active euthanasia, which introduces an external agency of harm. The ruling emphasized that the 'best interests' test for such decisions must consider both medical and non-medical factors, with a strong presumption in favor of preserving life.
- The Supreme Court granted approval for passive euthanasia in India's first judicial instance for a patient in a persistent vegetative state.
- The Court affirmed that the 'right to live with dignity' under Article 21 encompasses the 'right to die with dignity' for patients with irreversible medical conditions.
- Passive euthanasia is distinguished from active euthanasia by the absence of an external agency of harm, merely allowing the natural course of life.
Scientists have developed new ecological vaccination strategies for bats to protect them from deadly viruses like rabies and Nipah. The methods involve administering oral vaccines through food or as a topical gel, rather than traditional injections. This approach aims to prevent spillover events to humans and other animals by reducing viral loads in bat populations. The research, conducted by the U.S. Geological Survey and other institutions, has shown promising results in laboratory and simulated field tests, offering a less invasive and more scalable solution for wildlife vaccination.
- New ecological vaccination methods, including oral vaccines and topical gels, have been developed for bats.
- These methods aim to protect bats from deadly viruses like rabies and Nipah without invasive injections.
- The primary goal is to reduce viral loads in bat populations to prevent spillover to humans and other animals.
India ranks second globally in childhood obesity, with over 41 million children aged 5-19 having a high BMI, including 14 million with obesity, projected to rise to 56 million by 2040. Nutrition scientist Zeeshan Ali warns that this crisis, driven by rapid urbanization, poor diets, and high consumption of sugary drinks and unhealthy fats, is leading to a surge in pediatric chronic diseases traditionally associated with adults. He emphasizes the need for policy, socioeconomic, and household-level interventions, advocating for a return to indigenous foods and replacing refined oils and empty calories.
- India faces a severe childhood obesity crisis, ranking second globally, with projections indicating a significant increase by 2040.
- Rapid urbanization and a shift from traditional plant-based diets to processed foods are key drivers of this nutritional transition.
- Children are increasingly developing adult-onset diseases like type 2 diabetes, hypertension, and cardiovascular disease due to excess weight.
India, aligning with the Group for Equity, is pushing for a legally enforceable benefit-sharing system at the crucial World Health Organization (WHO) Pandemic Agreement talks in Geneva. This system would ensure that developing countries sharing pathogen materials and genetic sequence data receive fair and concrete benefits in return. The WHO Pandemic Agreement, adopted in May 2025, aims to address gaps and inequalities in global pandemic prevention and response, highlighted by COVID-19. The Group for Equity insists on standard, legally binding contracts for pathogen and sequence data sharing, ensuring benefits like a percentage of annual revenue from commercialized products or reserved production for WHO.
- India supports a legally enforceable benefit-sharing system for pathogen materials at WHO Pandemic Agreement talks.
- The system aims to ensure fair returns for developing countries sharing genetic sequence data.
- The WHO Pandemic Agreement was adopted in May 2025 to address global pandemic preparedness gaps.
The Supreme Court upheld the right to die with dignity for 32-year-old Harish Rana, who has been in a persistent vegetative state (PVS) for 13 years, by allowing the withdrawal of clinically assisted nutrition and hydration (CANH). This landmark ruling is the first implementation of the court's 2018 'passive euthanasia' guidelines. Justice J.B. Pardiwala emphasized that the decision reflects profound compassion and courage, allowing the individual to leave with dignity. The court also clarified the distinction between active and passive euthanasia, stating that passive euthanasia involves allowing death to occur by withdrawing life support, while active euthanasia introduces an external agency of harm.
- The Supreme Court allowed the withdrawal of clinically assisted nutrition and hydration (CANH) for Harish Rana, a man in a persistent vegetative state for 13 years.
- This ruling marks the first implementation of the Supreme Court's 2018 guidelines on 'passive euthanasia'.
- Justice J.B. Pardiwala highlighted that the decision is an act of compassion, allowing the individual to die with dignity.
The article highlights the alarming rise of childhood obesity and overweight, now impacting even younger children, traditionally associated with metabolic diseases in older age. The World Obesity Atlas 2026 projects a significant increase in obese and overweight children in India by 2040, leading to early signs of chronic illnesses like hypertension and cardiovascular disease. Causes include insufficient physical activity, unhealthy food consumption, poor access to healthy school meals, and sub-optimal breastfeeding. The World Obesity Federation calls for urgent action, including marketing restrictions, sugar levies, physical activity recommendations, mandatory breastfeeding, and healthier school food standards, to prevent a future health crisis and safeguard the nation's youth.
- Childhood obesity is a growing global and national health crisis, with metabolic diseases affecting younger populations.
- The World Obesity Atlas 2026 projects a substantial increase in obese and overweight children in India by 2040.
- Risk factors include insufficient activity, unhealthy food, poor access to healthy school meals, and sub-optimal breastfeeding.
The article highlights the severe issue of milk adulteration, particularly with ethylene glycol, leading to fatalities in states like Andhra Pradesh. It discusses the challenges in prosecuting offenders due to weak laws and the unorganized nature of the dairy sector. The government's efforts to ensure food safety, including the FSSAI's role in establishing safety protocols, are mentioned. The piece emphasizes the need for stricter penalties and a robust enforcement mechanism to protect consumers, especially vulnerable groups like children and the elderly, from the health risks posed by contaminated milk.
- Milk adulteration, particularly with ethylene glycol, poses a significant public health threat, leading to fatalities.
- The unorganized nature of the dairy sector and weak legal frameworks make it challenging to prosecute offenders effectively.
- The government, through bodies like FSSAI, is working to establish food safety protocols and ensure compliance.
The article analyzes the financial burden of cancer treatment in India, noting that it is three times higher than for other ailments. Medicines constitute the largest component of expenditure, especially in public hospitals in rural areas. While private hospitals charge more, the relative financial strain is higher in the government sector, particularly for the poor. The Budget's proposal for full exemption of basic customs duty on 17 cancer-related drugs is a crucial intervention. Data shows that the cost multiplier for cancer treatment in public hospitals increased from 4x in 2014 to 5x in 2017-18, highlighting the deepening financial strain on patients.
- Cancer treatment is significantly more expensive than other ailments, with medicines being the largest cost component.
- Despite lower absolute costs, the relative financial burden of cancer treatment is higher for patients in public hospitals, especially in rural areas.
- The Union Budget's full exemption of basic customs duty on 17 cancer-related drugs is a critical step to reduce patient costs.
The Union Budget 2026-27 proposes to train 1.5 lakh multiskilled caregivers, yet it overlooks the five million women already serving as Accredited Social Health Activists (ASHAs), Anganwadi workers, and mid-day meal workers. These women, classified as 'volunteers', perform essential public services but receive meager honorariums, lack formal contracts, and basic benefits, reflecting a "care penalty" rooted in gendered norms. The article argues that their work, being recurrent and central, should be converted into permanent posts, as supported by the Supreme Court's ruling in Dharam Singh & Anr. vs State of U.P. & Anr. Formalizing their roles and extending NSQF-aligned training to them is essential for India to build a robust care ecosystem and achieve its health ambitions.
- India's Budget focuses on training new caregivers but neglects existing 'volunteer' care workers like ASHAs and Anganwadi workers.
- These women perform essential, continuous services but lack formal employment benefits and receive meager honorariums due to gendered perceptions of care work.
- The Supreme Court's ruling in Dharam Singh & Anr. vs State of U.P. & Anr. supports converting recurrent 'volunteer' roles into permanent posts.
Breast cancer incidence in India has risen more than two-fold over the past three decades, reaching 29.4 cases per 100,000 women in 2023. Experts emphasize the need for regular screening and addressing gaps in treatment access for early detection. Key contributing factors identified include lifestyle changes, lack of breastfeeding, alcohol consumption, tobacco use, and sedentary work patterns. Challenges in tackling the rising incidence include resource scarcity, geographical accessibility, and inadequate care, particularly in remote areas.
- Breast cancer incidence in India has significantly increased over the last 30 years, highlighting a growing public health concern.
- Lifestyle changes, lack of breastfeeding, alcohol consumption, tobacco use, and sedentary work patterns are identified as major contributing factors.
- Early detection through regular screening and improved access to treatment are crucial for managing the rising incidence.
The inclusion of India's indigenous Cervavac HPV vaccine into the national immunisation programme has been delayed due to an ongoing ICMR study. This study aims to determine if a single dose of Cervavac generates a stable immune response comparable to Gardasil, following a relaxation by the WHO on HPV vaccine dosage. Previously, the WHO recommended a two-dose schedule, but now suggests single-dose options due to slow introduction and low coverage globally. While Prime Minister Modi launched a campaign using Gardasil-4, the ICMR study's results for Cervavac are expected in 2027, which will inform its official recommendation for a single-dose roll-out.
- The indigenous Cervavac HPV vaccine's inclusion in India's Universal Immunisation Programme (UIP) is pending an ICMR study.
- The study will assess if a single dose of Cervavac provides sufficient immune response compared to Gardasil.
- The World Health Organization (WHO) has relaxed its HPV vaccine dosage recommendations, now suggesting single-dose schedules for girls aged 9-15.
The article argues that while India has made significant strides in maternal health, women's midlife health remains largely invisible in policy and practice. As India's disease burden shifts towards Non-Communicable Diseases (NCDs), women in their 30s and 40s are experiencing higher rates of chronic conditions like hypertension and thyroid disorders, yet receive less structured attention. The invisibility extends to medical diagnostics, workplace design, and social realities, leading to late diagnoses and complex treatments. A life-course approach, broadening screening programs, and investing in women-specific health research are crucial to ensure women's dignified ageing and overall well-being, which benefits families, workplaces, and the economy.
- India has achieved significant success in maternal health, with a drastic fall in Maternal Mortality Ratio (MMR).
- However, women's health beyond childbearing years, particularly midlife health, is systemically invisible in policy and practice.
- Women in their 30s and 40s face higher rates of NCDs and chronic diseases but receive less attention.
The article discusses the potential of the Women's Reservation Act to create India's most gender-representative Parliament by 2029, reserving one-third of Lok Sabha seats for women. However, it emphasizes that mere presence is insufficient; real change requires addressing women-specific issues like elder care, which currently lacks a policy framework and gender dimension. India is ageing rapidly, with women disproportionately affected by lower savings, broken employment histories, and lack of caregivers. The author argues that political parties must integrate dignified ageing for women into their manifestos and campaigns now, not after the 2029 elections, to ensure meaningful impact.
- The Women's Reservation Act will reserve one-third of Lok Sabha seats for women by 2029, promising a more gender-representative Parliament.
- Effective representation requires addressing specific issues relevant to women, beyond just their presence in Parliament.
- Elder care for women is highlighted as a critical, unaddressed policy area, lacking a gender dimension in existing policies.
India is projected to have nearly 15 million children aged 5-9 and over 26 million aged 10-19 who are overweight or obese by 2025, ranking second globally after China. The World Obesity Atlas 2026 report highlights that the world is set to miss the 2025 global target to halve the rise in childhood obesity. Key risk factors in India include low physical activity levels, sub-optimal breastfeeding, and high consumption of sugary drinks, leading to projections of substantial increases in associated diseases like hypertension and hyperglycemia by 2040. Governments are urged to implement strong prevention and management efforts.
- India is projected to have the second-highest number of overweight or obese children globally by 2025, following China.
- The World Obesity Federation warns that global targets to reduce childhood obesity are being missed, with India being no exception.
- Significant risk factors contributing to childhood obesity in India include inadequate physical activity, sub-optimal breastfeeding, and high intake of sugary beverages.
The Supreme Court has decided to examine whether blood banks should be mandated to conduct the Nucleic Acid Test (NAT) for identifying diseases like HIV, Hepatitis B, and Hepatitis C. Currently, the less sensitive Enzyme-Linked Immunosorbent Assay (ELISA) test is more common. The petition, filed by an NGO, argues that safe blood transfusion is a fundamental part of the Right to Life under Article 21. The move follows reports of children contracting HIV through contaminated blood transfusions during treatment for Thalassemia. The Court has asked for data on the cost-effectiveness and feasibility of implementing NAT in state-run hospitals.
- NAT is a highly sensitive molecular technique that detects the genetic material of viruses, reducing the 'window period' for detection.
- The petition highlights that Thalassemia patients are particularly vulnerable due to frequent blood transfusions and contaminated blood risks.
- Article 21 of the Constitution (Right to Life) is being invoked to demand safer medical procedures across all state hospitals.
On Rare Diseases Day, concerns have been raised regarding the National Policy for Rare Diseases (NPRD) and the underutilization of allocated budgets. Despite a ₹299 crore allocation for 2025-26, only a small fraction (₹30.79 crore) has been utilized so far, leaving many patients without life-saving treatment. Families of children with disorders like MPS 2 and Gaucher disease report that funding caps of ₹50 lakh are insufficient for long-term care. The Supreme Court is scheduled to hear matters related to treatment interruptions, as the rare disease community calls for immediate intervention to ensure continuity of care and prevent further fatalities.
- The National Policy for Rare Diseases (NPRD) provides a framework for treatment through designated Centres of Excellence (CoEs) across India.
- A significant portion of the allocated budget remains unspent while patients face life-threatening delays in therapy due to administrative hurdles.
- The current funding cap of ₹50 lakh per patient is often exhausted quickly, leading to a complete halt in life-saving care for many children.